JP2019529364A5 - - Google Patents

Download PDF

Info

Publication number
JP2019529364A5
JP2019529364A5 JP2019510933A JP2019510933A JP2019529364A5 JP 2019529364 A5 JP2019529364 A5 JP 2019529364A5 JP 2019510933 A JP2019510933 A JP 2019510933A JP 2019510933 A JP2019510933 A JP 2019510933A JP 2019529364 A5 JP2019529364 A5 JP 2019529364A5
Authority
JP
Japan
Prior art keywords
membered
optionally substituted
cycloalkyl
alkyl
membered heterocycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019510933A
Other languages
English (en)
Japanese (ja)
Other versions
JP7050054B2 (ja
JP2019529364A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2017/098462 external-priority patent/WO2018036470A1/zh
Publication of JP2019529364A publication Critical patent/JP2019529364A/ja
Publication of JP2019529364A5 publication Critical patent/JP2019529364A5/ja
Application granted granted Critical
Publication of JP7050054B2 publication Critical patent/JP7050054B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019510933A 2016-08-22 2017-08-22 Pde4阻害剤としての縮合環系化合物 Active JP7050054B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201610706073 2016-08-22
CN201610706073.1 2016-08-22
PCT/CN2017/098462 WO2018036470A1 (zh) 2016-08-22 2017-08-22 作为pde4抑制剂的并环类化合物

Publications (3)

Publication Number Publication Date
JP2019529364A JP2019529364A (ja) 2019-10-17
JP2019529364A5 true JP2019529364A5 (cg-RX-API-DMAC10.html) 2020-08-06
JP7050054B2 JP7050054B2 (ja) 2022-04-07

Family

ID=61246426

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019510933A Active JP7050054B2 (ja) 2016-08-22 2017-08-22 Pde4阻害剤としての縮合環系化合物

Country Status (6)

Country Link
US (1) US10532986B2 (cg-RX-API-DMAC10.html)
EP (1) EP3502099B1 (cg-RX-API-DMAC10.html)
JP (1) JP7050054B2 (cg-RX-API-DMAC10.html)
CN (1) CN109563051B (cg-RX-API-DMAC10.html)
ES (1) ES2852098T3 (cg-RX-API-DMAC10.html)
WO (1) WO2018036470A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7237973B2 (ja) * 2018-01-29 2023-03-13 メッドシャイン ディスカバリー インコーポレイテッド 1H-イミダゾ[4,5-b]ピリジン-2(3H)-オン系化合物の結晶形及びその製造方法
WO2021000934A1 (zh) * 2019-07-04 2021-01-07 南京明德新药研发有限公司 一种苯并咪唑-2-酮类化合物的晶型、溶剂化物、溶剂化物的晶型及它们的制备方法
EP4101848A4 (en) * 2020-02-24 2023-07-26 Suzhou Longbotai Pharmaceuticals Co., Ltd. Pde4 inhibitor compound and medical use thereof
CN116783181B (zh) * 2021-04-12 2026-01-30 上海瑛派药业有限公司 取代的稠合双环类化合物作为parp抑制剂及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002072576A1 (en) 2001-03-09 2002-09-19 Pfizer Products Inc. Benzimidazole anti-inflammatory compounds
US7115644B2 (en) * 2002-09-13 2006-10-03 Boehringer Ingelheim Pharmaceuticals Inc. Heterocyclic compounds
US8119676B2 (en) * 2006-08-26 2012-02-21 Abbott GmbH & Co. HG Substituted benzimidazolone derivatives, medicaments comprising them and their use
WO2011021678A1 (ja) * 2009-08-21 2011-02-24 武田薬品工業株式会社 縮合複素環化合物
EP2603079B1 (en) * 2010-08-12 2018-09-19 Merck Sharp & Dohme Corp. Positive allosteric modulators of mglur2
MD20150071A2 (ro) 2013-02-19 2016-02-29 Pfizer Inc. Compuşi azabenzimidazolici ca inhibitori ai PDE4 izoenzimelor pentru tratamentul tulburărilor SNC şi altor afecţiuni
KR102307566B1 (ko) * 2013-06-21 2021-10-05 제니쓰 에피제네틱스 리미티드 신규한 바이사이클릭 브로모도메인 억제제
JP2014114308A (ja) 2014-01-31 2014-06-26 Celgene Corp (+)−2−[1−(3−エトキシ−4−メトキシフェニル)−2−メチルスルホニルエチル]−4−アセチルアミノイソインドリン−1,3−ジオンを含む固形物形態、その組成物およびその使用
AR101196A1 (es) 2014-07-16 2016-11-30 Gruenenthal Gmbh Compuestos de pirimidina sustituidos

Similar Documents

Publication Publication Date Title
JP2016514192A5 (cg-RX-API-DMAC10.html)
HRP20201985T1 (hr) Piridonski spoj kao c-met inhibitor
RU2015144224A (ru) Амин-функциональные полиамиды
MX2024004789A (es) Esteroides neuroactivos y sus metodos de uso.
JP2018529650A5 (cg-RX-API-DMAC10.html)
JP2019531279A5 (cg-RX-API-DMAC10.html)
JP2016516020A5 (cg-RX-API-DMAC10.html)
JP2019524883A5 (cg-RX-API-DMAC10.html)
JP2017523225A5 (cg-RX-API-DMAC10.html)
JP2020507589A5 (cg-RX-API-DMAC10.html)
JP2011519854A5 (cg-RX-API-DMAC10.html)
JP2015024998A5 (cg-RX-API-DMAC10.html)
RU2019108189A (ru) Ингибитор pde4
JP2016506935A5 (cg-RX-API-DMAC10.html)
JP2016526558A5 (cg-RX-API-DMAC10.html)
JP2014511891A5 (cg-RX-API-DMAC10.html)
ATE528276T1 (de) Lysophosphatidylsäurerezeptor-antagonistische verbindungen und ihre anwendungen
JP2016503797A5 (cg-RX-API-DMAC10.html)
JP2019512550A5 (cg-RX-API-DMAC10.html)
JP2019516739A5 (cg-RX-API-DMAC10.html)
JP2019532092A5 (cg-RX-API-DMAC10.html)
JP2015526453A5 (cg-RX-API-DMAC10.html)
JP2015526455A5 (cg-RX-API-DMAC10.html)
RU2018146128A (ru) НОВЫЕ ИНГИБИТОРЫ β-ЛАКТАМАЗ
JP2016521695A5 (cg-RX-API-DMAC10.html)